Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes

141Citations
Citations of this article
166Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. The 3 PPAR isotypes, PPAR-α, PPAR-γ, and PPAR-δ, play a key role in the regulation of lipid and glucose metabolism. Obesity and the interrelated disorders of the metabolic syndrome have become a major worldwide health problem. In this review, we summarize the critical role of PPARs in regulating inflammation, lipoprotein metabolism, and glucose homeostasis and their potential implications for the treatment of obesity, diabetes, and atherosclerosis. © 2005 American Heart Association, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006, January). Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.ATV.0000191663.12164.77

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free